NCT00160615View on ClinicalTrials.gov

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

PHASE3CompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

September 12, 2001

Primary Completion Date

January 17, 2007

Study Completion Date

January 17, 2007

Conditions

Epilepsy, Partial

Interventions

DRUG

Levetiracetam

"* Pharmaceutical form: Film-coating tablets~* Concentration: 250 mg/ 500 mg~* Route of administration: oral use"

All Listed Sponsors

lead

UCB Japan Co. Ltd.

INDUSTRY

NCT00160615 - Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method | Biotech Hunter | Biotech Hunter